Healthcare Digital July 8, 2024
Sean Ashcroft

Nestlé Health Science launches nutrition initiative to counteract side effects of weight-loss drugs, including hollowed-out ‘Ozempic Face’

The surge in sales of weight loss drugs – particularly in the US – is having a ripple effect on other markets, both in the foods and healthcare sectors.

Weight loss drugs are believed to be behind a fall in demand for the kind of foods associated with weight gain. Analysts at Morgan Stanley estimate that US consumption of fizzy soft drinks, baked goods and salty snacks could fall by up to 3% by 2035.

These drugs are also reshaping the healthcare industry, as people seek solutions to some of the unwanted cosmetic effects of rapid weight loss.

One such effect is so-called...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Patient / Consumer, Pharma / Biotech, Provider, Retailer
What to expect from healthcare providers and retailers this year
The Year in Amazon vs Walmart, and a Look Into 2025
AI, Omnichannel and Social Commerce: Inside the 2024 D2C Transformation
How AI Reshaped Retail in 2024: 10 Key Developments
How AI Is Quietly Transforming E-Commerce Search And Discovery

Share This Article